Effects of Long-Term Carprofen and Omeprazole Administration in C57BL/6J Mice.

Abby Bernardini, Brianne Taylor, Matlock Jeffries
{"title":"Effects of Long-Term Carprofen and Omeprazole Administration in C57BL/6J Mice.","authors":"Abby Bernardini, Brianne Taylor, Matlock Jeffries","doi":"10.30802/AALAS-JAALAS-25-069","DOIUrl":null,"url":null,"abstract":"<p><p>Osteoarthritis is the leading cause of disability in the United States and affects approximately half of adults over the age of 65. Many osteoarthritis patients take nonsteroidal anti-inflammatory drugs (NSAIDs) on a long-term basis, often concurrently with proton pump inhibitors (PPIs), such as omeprazole, to prevent gastric ulceration. Mice (Mus musculus) are a commonly used animal model of osteoarthritis. There are little data regarding long-term administration of NSAIDs or coadministration of PPIs and NSAIDs in mice. This study sought to determine if administration of carprofen, a commonly used veterinary NSAID, has adverse effects when administered for 21 days and if coadministration of omeprazole reduces the incidence of adverse effects. Four groups of C57BL/6J male (n = 5/group) and female (n = 5/group) mice were weighed daily and administered 10 mg/kg carprofen and 8.2 mg/kg omeprazole, 10 mg/kg carprofen, 8.2 mg/kg omeprazole, or control suspension once daily by oral gavage for 21 days. All mice were euthanized, and complete blood count (CBC), serum chemistry, fecal occult blood, and pyloric histopathology and gastritis scoring were conducted. All animals remained clinically healthy for the duration of the study. White blood cell counts (WBCs) and platelets were significantly lower in the carprofen and omeprazole group. Neutrophil counts were significantly lower in the carprofen and omeprazole and the carprofen groups. Compared with the control group, albumin was significantly higher in the carprofen group. Fecal occult blood tests were negative for all animals. No animals had pyloric mucosal ulceration, and gastritis scores were not significantly different between groups. Body weight significantly decreased for all groups over time, with no significant differences among treatment groups. Carprofen and omeprazole may be safely administered to C57BL/6J mice for 21 days but may induce significant changes in CBC and serum chemistry.</p>","PeriodicalId":94111,"journal":{"name":"Journal of the American Association for Laboratory Animal Science : JAALAS","volume":" ","pages":"1-7"},"PeriodicalIF":0.0000,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the American Association for Laboratory Animal Science : JAALAS","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.30802/AALAS-JAALAS-25-069","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Osteoarthritis is the leading cause of disability in the United States and affects approximately half of adults over the age of 65. Many osteoarthritis patients take nonsteroidal anti-inflammatory drugs (NSAIDs) on a long-term basis, often concurrently with proton pump inhibitors (PPIs), such as omeprazole, to prevent gastric ulceration. Mice (Mus musculus) are a commonly used animal model of osteoarthritis. There are little data regarding long-term administration of NSAIDs or coadministration of PPIs and NSAIDs in mice. This study sought to determine if administration of carprofen, a commonly used veterinary NSAID, has adverse effects when administered for 21 days and if coadministration of omeprazole reduces the incidence of adverse effects. Four groups of C57BL/6J male (n = 5/group) and female (n = 5/group) mice were weighed daily and administered 10 mg/kg carprofen and 8.2 mg/kg omeprazole, 10 mg/kg carprofen, 8.2 mg/kg omeprazole, or control suspension once daily by oral gavage for 21 days. All mice were euthanized, and complete blood count (CBC), serum chemistry, fecal occult blood, and pyloric histopathology and gastritis scoring were conducted. All animals remained clinically healthy for the duration of the study. White blood cell counts (WBCs) and platelets were significantly lower in the carprofen and omeprazole group. Neutrophil counts were significantly lower in the carprofen and omeprazole and the carprofen groups. Compared with the control group, albumin was significantly higher in the carprofen group. Fecal occult blood tests were negative for all animals. No animals had pyloric mucosal ulceration, and gastritis scores were not significantly different between groups. Body weight significantly decreased for all groups over time, with no significant differences among treatment groups. Carprofen and omeprazole may be safely administered to C57BL/6J mice for 21 days but may induce significant changes in CBC and serum chemistry.

长期服用卡洛芬和奥美拉唑对C57BL/6J小鼠的影响。
在美国,骨关节炎是导致残疾的主要原因,影响了大约一半的65岁以上的成年人。许多骨关节炎患者长期服用非甾体抗炎药(NSAIDs),通常同时服用质子泵抑制剂(PPIs),如奥美拉唑,以预防胃溃疡。小鼠(小家鼠)是骨关节炎常用的动物模型。关于小鼠长期服用非甾体抗炎药或PPIs和非甾体抗炎药联合使用的数据很少。本研究旨在确定卡洛芬(一种常用的兽医用非甾体抗炎药)在给药21天后是否会产生不良反应,以及奥美拉唑是否会减少不良反应的发生率。4组C57BL/6J雄性小鼠(n = 5只/组)和雌性小鼠(n = 5只/组)每天称重,分别给予10 mg/kg卡洛芬和8.2 mg/kg奥美拉唑、10 mg/kg卡洛芬、8.2 mg/kg奥美拉唑或对照混悬液,每天1次灌胃,连续灌胃21 d。所有小鼠均被安乐死,并进行全血细胞计数(CBC)、血清化学、粪便隐血、幽门组织病理学和胃炎评分。所有动物在研究期间均保持临床健康。卡洛芬和奥美拉唑组白细胞计数(wbc)和血小板明显降低。中性粒细胞计数在卡洛芬和奥美拉唑组和卡洛芬组显著降低。与对照组相比,卡洛芬组白蛋白明显升高。所有动物的粪便潜血试验均为阴性。各组动物无幽门黏膜溃疡,胃炎评分差异无统计学意义。随着时间的推移,所有组的体重都显著下降,治疗组之间没有显著差异。卡洛芬和奥美拉唑可以安全地给药C57BL/6J小鼠21天,但可能引起CBC和血清化学的显著变化。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信